These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 6321850)

  • 21. Role of angiotensin converting enzyme inhibitors in essential and renal hypertension. Effects of captopril and enalapril on renin-angiotensin-aldosterone, renal function and hemodynamics, salt and water excretion, and body fluid composition.
    Bauer JH
    Am J Med; 1984 Aug; 77(2A):43-51. PubMed ID: 6206722
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Captopril versus enalapril maleate: a comparison of antihypertensive and hormonal effects.
    Lewis RA; Baker KM; Ayers CR; Weaver BA; Lehman MR
    J Cardiovasc Pharmacol; 1985; 7 Suppl 1():S12-5. PubMed ID: 2580164
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Renal insufficiency after administration of captopril in renal artery stenosis with a single kidney or bilateral stenosis is not compulsory].
    Durand D; Tran Van T; Ader JL; Suc JM
    Arch Mal Coeur Vaiss; 1984 Oct; 77(11):1272-7. PubMed ID: 6441547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antihypertensive effects of captopril and saralasin in essential and renal hypertension.
    Konrads A; Meurer KA; Hummerich W; Wambach G; Kindler J; Feltkamp H; Helber A
    Am J Cardiol; 1982 Apr; 49(6):1558-60. PubMed ID: 7041597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Use of captopril in arterial hypertension with a stable and malignant course].
    Lordkipanidze NL
    Biull Vsesoiuznogo Kardiol Nauchn Tsentra AMN SSSR; 1984; 7(1):111-7. PubMed ID: 6145432
    [No Abstract]   [Full Text] [Related]  

  • 26. Converting-enzyme inhibition for severe chronic heart failure: views from a skeptic.
    Packer M
    Int J Cardiol; 1985 Feb; 7(2):111-20. PubMed ID: 2982750
    [No Abstract]   [Full Text] [Related]  

  • 27. [Progressive reversible kidney insufficiency after blood pressure reduction with captopril].
    Kindler J; Konrads A; Meurer KA; Sieberth HG
    Internist (Berl); 1981 Jun; 22(6):360-3. PubMed ID: 6265394
    [No Abstract]   [Full Text] [Related]  

  • 28. Reversible renal failure and captopril therapy in renovascular hypertension.
    Wiggelinkhuizen J
    S Afr Med J; 1987 Mar; 71(5):332-3. PubMed ID: 3551124
    [No Abstract]   [Full Text] [Related]  

  • 29. Resolution of captopril-induced rash after substitution of enalapril.
    Rotmensch HH; Vlasses PH; Ferguson RK
    Pharmacotherapy; 1983; 3(2 Pt 1):131-3. PubMed ID: 6304662
    [No Abstract]   [Full Text] [Related]  

  • 30. Enalapril and lisinopril in renovascular hypertension--antihypertensive and hormonal effects of two new angiotensin-converting-enzyme (ACE) inhibitors. A preliminary report.
    Karlberg BE; Fyhrquist F; Grönhagen-Riska C; Tikkanen I; Ohman KP
    Scand J Urol Nephrol Suppl; 1984; 79():103-6. PubMed ID: 6089307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Converting-enzyme inhibitor enalapril (MK421) in treatment of hypertension with renal artery stenosis.
    Hodsman GP; Brown JJ; Davies DL; Fraser R; Lever AF; Morton JJ; Murray GD; Robertson JI
    Br Med J (Clin Res Ed); 1982 Dec; 285(6356):1697-9. PubMed ID: 6293638
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Enalapril, a rash, and captopril.
    Kubo SH; Cody RJ
    Ann Intern Med; 1984 Apr; 100(4):616. PubMed ID: 6322634
    [No Abstract]   [Full Text] [Related]  

  • 33. Captopril and enalapril: angiotensin converting enzyme (ACE) inhibitors.
    Ferguson RK; Vlasses PH; Riley LJ
    Ration Drug Ther; 1984 Mar; 18(3):1-5. PubMed ID: 6093192
    [No Abstract]   [Full Text] [Related]  

  • 34. Captopril and enalapril.
    Wilkin JK
    Ann Intern Med; 1983 Aug; 99(2):281. PubMed ID: 6309052
    [No Abstract]   [Full Text] [Related]  

  • 35. The renin-angiotensin system in refractory heart failure: clinical, hemodynamic and hormonal effects of captopril and enalapril.
    Turini GA; Waeber B; Brunner HR
    Eur Heart J; 1983 Jan; 4 Suppl A():189-97. PubMed ID: 6301835
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A parallel study of enalapril and captopril and 1 year of experience with enalapril treatment in moderate-to-severe essential hypertension.
    Thind GS; Johnson A; Bhatnagar D; Henkel TW
    Am Heart J; 1985 Apr; 109(4):852-8. PubMed ID: 2984913
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Participation of the renin system in treatment-resistant hypertension as measured by acute blockade of the angiotensin converting enzyme.
    Weber MA; Drayer JI; Priest RT; Chen TC
    Am J Nephrol; 1982; 2(1):6-11. PubMed ID: 6295161
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Enalapril versus triple-drug therapy in the treatment of renovascular hypertension.
    Reams GP; Bauer JH
    Drugs; 1985; 30 Suppl 1():59-69. PubMed ID: 2994988
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormonal and metabolic effects of angiotensin converting enzyme inhibitors. Possible differences between enalapril and captopril.
    Atlas SA; Case DB; Yu ZY; Laragh JH
    Am J Med; 1984 Aug; 77(2A):13-7. PubMed ID: 6089554
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Captopril, an orally active angiotensin I converting enzyme inhibitor in the treatment of renovascular and essential hypertension.
    Holtzman E; Rosenthal T; Stern N; Knecht A; Yaron A
    Isr J Med Sci; 1982 May; 18(5):597-602. PubMed ID: 6284678
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.